Cells were pretreated with the growth factors PDGF-B, PDGF-D, hepatocyte growth factor, and connective tissue growth factor (all known to be expressed in CCA (6, 19, 21)) to achieve an activated phenotype and subsequently exposed to the BH3 mimetic navitoclax. The gene discussed is PDGFD; the disease is cholangiocarcinoma.